文献速递系统性红斑狼疮

系统性红斑狼疮外周神经系统病变:国际起始队列研究结果

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
PubMed 文献 · Arthritis Rheumatol · 2019-11-28

该研究基于多民族/多种族系统性红斑狼疮(SLE)前瞻性起始队列,评估外周神经系统(PNS)病变的频率、临床特征、相关因素及结局。1,827例SLE患者中139例(7.6%)发生161次PNS事件,以周围神经病、单神经病和颅神经病为主,多数归因于SLE。PNS病变显著降低健康相关生活质量,但多数患者经医生评估后缓解或改善,若干因素与缓解时间延长相关。

要点

  • SLE患者PNS事件发生率为7.6%(139/1,827),以周围神经病(41.0%)、单神经病(27.3%)和颅神经病(24.2%)为主。
  • 神经病史、SLE诊断时年龄较大、SLEDAI-2K评分较高及周围神经病(对比其他神经病)与缓解时间延长相关。
  • 神经病与SF-36躯体及心理成分汇总评分显著降低相关,但多数患者缓解或改善且伴随评分改善。

核心结论

  • PNS病变是总NPSLE的重要组成部分,对健康相关生活质量有显著负面影响。
  • 多数患者结局良好,但若干因素与缓解时间延长相关。

研究设计与样本

  • 多民族/多种族前瞻性SLE起始队列研究,共纳入1,827例SLE患者。
  • 每年评估19种神经精神(NP)事件,包括7种PNS病变,并测量SLE疾病活动度、器官损伤、自身抗体及患者与医生对结局的评估。
  • 采用事件发生时间分析和线性回归分析。

主要发现

  • 1,827例患者中139例(7.6%)共发生161次PNS事件。
  • 主要事件为周围神经病(66/161,41.0%)、单神经病(44/161,27.3%)和颅神经病(39/161,24.2%),多数归因于SLE。
  • 多因素Cox回归提示,有神经病史、SLE诊断时年龄较大、SLEDAI-2K评分较高以及周围神经病(对比其他神经病)的患者缓解时间更长。
  • 神经病与无NP事件者相比,SF-36躯体成分汇总评分和心理成分汇总评分显著降低。
  • 根据医生评估,多数神经病随时间缓解或改善,且周围神经病和单神经病的改善与SF-36汇总评分改善相关。

临床怎么用

  • 对SLE患者应关注PNS病变的评估,因其对健康相关生活质量有显著负面影响。
  • 识别与缓解时间延长相关的因素(神经病史、诊断时年龄较大、SLEDAI-2K评分较高、周围神经病)有助于预后判断和随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the frequency, clinical characteristics, associations, and outcomes of different types of peripheral nervous system (PNS) disease in a multiethnic/multiracial, prospective inception cohort of systemic lupus erythematosus (SLE) patients. METHODS: Patients were evaluated annually for 19 neuropsychiatric (NP) events including 7 types of PNS disease. SLE disease activity, organ damage, autoantibodies, and patient and physician assessment of outcome were measured. Time to event and linear regressions were used as appropriate. RESULTS: Of 1,827 SLE patients, 88.8% were female, and 48.8% were white. The mean ± SD age was 35.1 ± 13.3 years, disease duration at enrollment was 5.6 ± 4.2 months, and follow-up was 7.6 ± 4.6 years. There were 161 PNS events in 139 (7.6%) of 1,827 patients. The predominant events were peripheral neuropathy (66 of 161 [41.0%]), mononeuropathy (44 of 161 [27.3%]), and cranial neuropathy (39 of 161 [24.2%]), and the majority were attributed to SLE. Multivariate Cox regressions suggested longer time to resolution in patients with a history of neuropathy, older age at SLE diagnosis, higher SLE Disease Activity Index 2000 scores, and for peripheral neuropathy versus other neuropathies. Neuropathy was associated with significantly lower Short Form 36 (SF-36) physical and mental component summary scores versus no NP events. According to physician assessment, the majority of neuropathies resolved or improved over time, which was associated with improvements in SF-36 summary scores for peripheral neuropathy and mononeuropathy. CONCLUSION: PNS disease is an important component of total NPSLE and has a significant negative impact on health-related quality of life. The outcome is favorable for most patients, but our findings indicate that several factors are associated with longer time to resolution.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hanly JG, Li Q, Su L, et al. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2019. PMID: 31390162. doi:10.1002/art.41070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。